Pvolve announced a new partnership with Tally Health to integrate science-driven fitness and biological age insights aimed at supporting longevity. According to the companies, the collaboration will blend Pvolve’s low-impact, functional fitness programs with Tally Health’s epigenetic testing platform to offer members a more data-informed approach to wellness.
The companies said that through this partnership, Pvolve members will have access to Tally Health’s at-home DNA methylation test, which estimates biological age based on epigenetic markers. Pvolve claims this will enable users to track how consistent movement and lifestyle changes may affect cellular aging over time.
As part of the initiative, educational content will be developed to help members understand the relationship between movement, longevity, and epigenetic health. The partnership also plans to introduce special promotions and joint programming to deepen engagement.
Pvolve stated that its method focuses on functional movements designed to improve strength, mobility, and balance while being gentle on joints. Tally Health said its test leverages scientific research to offer consumers actionable insights into their biological age and potential health risks.
Financial details of the agreement were not disclosed. The companies positioned the partnership as part of a broader strategy to provide members with personalized wellness tools grounded in scientific research.
